Stay updated on First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Sign up to get notified when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Version tag updated from v3.0.1 to v3.0.2; the old tag was removed and the 'Back to Top' link was deleted.
    Difference
    0.2%
    Check dated 2025-09-13T17:42:34.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-06T15:25:56.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the addition of new facility names and locations, as well as updated drug information for Tarlatamab, Durvalumab, and Atezolizumab. Notably, several previous entries related to lung cancer and specific locations have been removed.
    Difference
    8%
    Check dated 2025-08-30T12:12:14.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:49:21.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T00:18:17.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and the previous service alert regarding planned maintenance has been removed.
    Difference
    0.9%
    Check dated 2025-08-01T19:33:02.000Z thumbnail image

Stay in the know with updates to First-Line Tarlatamab Combo in ES-SCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the First-Line Tarlatamab Combo in ES-SCLC Clinical Trial page.